Evaluation of peripheral nerve regeneration via in vivo serial transcutaneous imaging using transgenic Thy1-YFP mice

Experimental Neurology

Volumn 232, Issue 1, 2011, Pages 7-14

  Yan, Ying ^a   Sun, Hank H ^a   Mackinnon, Susan E ^a   Johnson, Philip J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conditioning injury; FK 506; GFAP GDNF (glial fibrillary acidic protein); Live imaging; Nerve crush; Nerve regeneration; Thy1 YFP mouse

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; TACROLIMUS; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESPONSE; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; IMAGE ANALYSIS; IN VIVO STUDY; MOUSE; NERVE CRUSH; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SAPHENOUS NERVE; THY1 GENE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, THY-1; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, TRANSGENIC; NERVE CRUSH; NERVE REGENERATION; NERVE TISSUE PROTEINS; PERIPHERAL NERVE INJURIES; PERIPHERAL NERVES; TACROLIMUS; TREATMENT OUTCOME;

EID: 80053955733     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.06.013     Document Type: Article

References (67)

1. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., Stevenson M.A., Calderwood S.K. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002, 277:15028-15034.
2. Boivin A., Pineau I., Barrette B., Filali M., Vallieres N., Rivest S., Lacroix S. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci. 2007, 27:12565-12576.
3. Boyd J.G., Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol. Neurobiol. 2003, 27:277-324.
4. Brenner M.J., Mackinnon S.E., Rickman S.R., Jaramillo A., Tung T.H., Hunter D.A., Mohanakumar T. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation. Restor. Neurol. Neurosci. 2005, 23:237-249.
5. Brenner M.J., Moradzadeh A., Myckatyn T.M., Tung T.H., Mendez A.B., Hunter D.A., Mackinnon S.E. Role of timing in assessment of nerve regeneration. Microsurgery 2008, 28:265-272.
6. Chabas J.F., Alluin O., Rao G., Garcia S., Lavaut M.N., Legre R., Magalon G., Marqueste T., Feron F., Decherchi P. FK506 induces changes in muscle properties and promotes metabosensitive nerve fiber regeneration. J. Neurotrauma 2009, 26:97-108.
7. Chunasuwankul R., Ayrout C., Dereli Z., Gal A., Lanzetta M., Owen E. Low dose discontinued FK506 treatment enhances peripheral nerve regeneration. Int. Surg. 2002, 87:274-278.
8. Doolabh V.B., Mackinnon S.E. FK506 accelerates functional recovery following nerve grafting in a rat model. Plast. Reconstr. Surg. 1999, 103:1928-1936.
9. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
10. Forman D.S., McQuarrie I.G., Labore F.W., Wood D.K., Stone L.S., Braddock C.H., Fuchs D.A. Time course of the conditioning lesion effect on axonal regeneration. Brain Res. 1980, 182:180-185.
11. Fu S.Y., Gordon T. Contributing factors to poor functional recovery after delayed nerve repair: prolonged axotomy. J. Neurosci. 1995, 15:3876-3885.
12. Fu S., Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol. Neurobiol. 1997, 14:67-116.
13. Fugleholm K., Schmalbruch H., Krarup C. Early peripheral nerve regeneration after crushing, sectioning, and freeze studied by implanted electrodes in the cat. J. Neurosci. 1994, 14:2659-2673.
14. Giffard R.G., Xu L., Zhao H., Carrico W., Ouyang Y., Qiao Y., Sapolsky R., Steinberg G., Hu B., Yenari M.A. Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J. Exp. Biol. 2004, 207:3213-3220.
15. Gold B.G. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. Drug Metab. Rev. 1999, 31:649-663.
16. Gold B.G., Zhong Y.P. FK506 requires stimulation of the extracellular signal-regulated kinase 1/2 and the steroid receptor chaperone protein p23 for neurite elongation. Neurosignals 2004, 13:122-129.
17. Gold B.G., Storm-Dickerson T., Austin D.R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 1994, 6:287-296.
18. Gold B.G., Katoh K., Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 1995, 15:7509-7516.
19. Gold B.G., Yew J.Y., Zeleny-Pooley M. The immunosuppressant FK506 increases GAP-43 mRNA levels in axotomized sensory neurons. Neurosci. Lett. 1998, 241:25-28.
20. Gold B.G., Densmore V., Shou W., Matzuk M.M., Gordon H.S. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 1999, 289:1202-1210.
21. Gold B.G., Gordon H.S., Wang M.S. Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect. Neurosci. Lett. 1999, 267:33-36.
22. Gordon T., Sulaiman O., Gordon Boyd Experimental strategies to promote functional recovery after peripheral nerve injuries. J. Peripher. Nerv. Syst. 2003, 8(4):236-250.
23. Hare G.M., Evans P.J., Mackinnon S.E., Best T.J., Bain J.R., Szalai J.P., Hunter D.A. Walking track analysis: a long-term assessment of peripheral nerve recovery. Plast. Reconstr. Surg. 1992, 89:251-258.
24. Hayashi A., Pannucci C., Moradzadeh A., Kawamura D., Magill C., Hunter D.A., Tong A.Y., Parsadanian A., Mackinnon S.E., Myckatyn T.M. Axotomy or compression is required for axonal sprouting following end-to-side neurorrhaphy. Exp. Neurol. 2008, 211:539-550.
25. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R.A., Simpson L.C., et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994, 266:1062-1064.
26. Hunter D.A., Moradzadeh A., Whitlock E.L., Brenner M.J., Myckatyn T.M., Wei C.H., Tung T.H., Mackinnon S.E. Binary imaging analysis for comprehensive quantitative histomorphometry of peripheral nerve. J. Neurosci. Methods 2007, 166:116-124.
27. Jensen J.N., Brenner M.J., Tung T.H., Hunter D.A., Mackinnon S.E. Effect of FK506 on peripheral nerve regeneration through long grafts in inbred swine. Ann. Plast. Surg. 2005, 54:420-427.
28. Jost S.C., Doolabh V.B., Mackinnon S.E., Lee M., Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor. Neurol. Neurosci. 2000, 17:39-44.
29. Kobayashi J., Mackinnon S.E., Watanabe O., Ball D.J., Gu X.M., Hunter D.A., Kuzon W.M. The effect of duration of muscle denervation on functional recovery in the rat model. Muscle Nerve 1997, 20:858-866.
30. Kwon H.M., Kim Y.J., Ryu S., Yang S.I., Lee S.H., Yoon B.W. Differential expression of HSP70 mRNA in the mouse brain after treatment with geldanamycin. Neurol. Res. 2009, 31:541-544.
31. Lankford K.L., Waxman S.G., Kocsis J.D. Mechanisms of enhancement of neurite regeneration in vitro following a conditioning sciatic nerve lesion. J. Comp. Neurol. 1998, 391:11-29.
32. Lee M., Doolabh V.B., Mackinnon S.E., Jost S. FK506 and Cyclosporin A promote functional recovery in crushed rat sciatic nerve. Muscle Nerve 2000, 23:633-640.
33. Lee M., Doolabh V.B., Mackinnon S.E., Jost S. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 2000, 23:633-640.
34. Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp. Neurol. 2007, 203:457-471.
35. Liebelt B., Papapetrou P., Ali A., Guo M., Ji X., Peng C., Rogers R., Curry A., Jimenez D., Ding Y. Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating heat shock protein-70 (heat shock protein-72) and extracellular-signal-regulated-kinase 1/2. Neuroscience 2010, 166:1091-1100.
36. Mackinnon S.E., Dellon A.L. Surgery of the Peripheral Nerve 1988, Thieme Medical Publishers, G. Thieme Verlag, New York, Stuttgart; New York.
37. Magill C.K., Moore A.M., Yan Y., Tong A.Y., MacEwan M.R., Yee A., Hayashi A., Hunter D.A., Ray W.Z., Johnson P.J., Parsadanian A., Myckatyn T.M., Mackinnon S.E. The differential effects of pathway- versus target-derived glial cell line-derived neurotrophic factor on peripheral nerve regeneration. J. Neurosurg. 2010, 113:102-109.
38. Marsh B.J., Williams-Karnesky R.L., Stenzel-Poore M.P. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 2009, 158:1007-1020.
39. Matsumori Y., Hong S.M., Aoyama K., Fan Y., Kayama T., Sheldon R.A., Vexler Z.S., Ferriero D.M., Weinstein P.R., Liu J. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J. Cereb. Blood Flow Metab. 2005, 25:899-910.
40. McLeod M., Hong M., Mukhida K., Sadi D., Ulalia R., Mendez I. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur. J. Neurosci. 2006, 24:361-370.
41. McQuarrie I.G. The effect of a conditioning lesion on the regeneration of motor axons. Brain Res. 1978, 152:597-602.
42. Myckatyn T.M., Hunter D.A., Mackinnon S.E. The effects of cold preservation and subimmunosuppressive doses of FK506 on axonal regeneration in murine peripheral nerve isografts. Can. J. Plast. Surg. 2003, 11:15-22.
43. Navarro X., Udina E. Chapter 6: Methods and protocols in peripheral nerve regeneration experimental research: part III-electrophysiological evaluation. Int. Rev. Neurobiol. 2009, 87:105-126.
44. Nichols C.M., Myckatyn T.M., Rickman S.R., Fox I.K., Hadlock T., Mackinnon S.E. Choosing the correct functional assay: a comprehensive assessment of functional tests in the rat. Behav. Brain Res. 2005, 163:143-158.
45. Pan Y.A., Misgeld T., Lichtman J.W., Sanes J.R. Effects of neurotoxic and neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo. J. Neurosci. 2003, 23:11479-11488.
46. Perlson E., Hanz S., Ben-Yaakov K., Segal-Ruder Y., Seger R., Fainzilber M. Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. Neuron 2005, 45:715-726.
47. Pet M.A., Ray W.Z., Yee A., Mackinnon S.E. Nerve transfer to the triceps after brachial plexus injury: report of four cases. J. Hand Surg. Am. 2011, 36:398-405.
48. Qiu J., Cafferty W.B., McMahon S.B., Thompson S.W. Conditioning injury-induced spinal axon regeneration requires signal transducer and activator of transcription 3 activation. J. Neurosci. 2005, 25:1645-1653.
49. Ray W.Z., Pet M.A., Yee A., Mackinnon S.E. Double fascicular nerve transfer to the biceps and brachialis muscles after brachial plexus injury: clinical outcomes in a series of 29 cases. J. Neurosurg. 2011, 114:1520-1528.
50. Sjoberg J., Kanje M. Effects of repetitive conditioning crush lesions on regeneration of the rat sciatic nerve. Brain Res. 1990, 530:167-169.
51. Snyder A.K., Fox I.K., Nichols C.M., Rickman S.R., Hunter D.A., Tung T.H., Mackinnon S.E. Neuroregenerative effects of preinjury FK-506 administration. Plast. Reconstr. Surg. 2006, 118:360-367.
52. Sobol J.B., Lowe I.J., Yang R.K., Sen S.K., Hunter D.A., Mackinnon S.E. Effects of delaying FK506 administration on neuroregeneration in a rodent model. J. Reconstr. Microsurg. 2003, 19:113-118.
53. Sulaiman O.A., Voda J., Gold B.G., Gordon T. FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic Schwann cell denervation. Exp. Neurol. 2002, 175:127-137.
54. Tannemaat M.R., Eggers R., Hendriks W.T., de Ruiter G.C., van Heerikhuize J.J., Pool C.W., Malessy M.J., Boer G.J., Verhaagen J. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve. Eur. J. Neurosci. 2008, 28:1467-1479.
55. Tonge D., Chan K., Zhu N., Panjwani A., Arno M., Lynham S., Ward M., Snape A., Pizzey J. Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins. J. Cell Sci. 2008, 121:2565-2577.
56. Udina E., Ceballos D., Verdu E., Gold B.G., Navarro X. Bimodal dose-dependence of FK506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve 2002, 26:348-355.
57. Udina E., Ceballos D., Gold B.G., Navarro X. FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp. Neurol. 2003, 183:220-231.
58. Udina E., Voda J., Gold B.G., Navarro X. Comparative dose-dependence study of FK506 on transected mouse sciatic nerve repaired by allograft or xenograft. J. Peripher. Nerv. Syst. 2003, 8:145-154.
59. Udina E., Gold B.G., Navarro X. Comparison of continuous and discontinuous FK506 administration on autograft or allograft repair of sciatic nerve resection. Muscle Nerve 2004, 29:812-822.
60. Unezaki S., Yoshii S., Mabuchi T., Saito A., Ito S. Effects of neurotrophic factors on nerve regeneration monitored by in vivo imaging in thy1-YFP transgenic mice. J. Neurosci. Methods 2009, 178:308-315.
61. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 2002, 277:15107-15112.
62. Wang M.S., Zeleny-Pooley M., Gold B.G. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther. 1997, 282:1084-1093.
63. Wood M.D., Moore A.M., Hunter D.A., Tuffaha S., Borschel G.H., Mackinnon S.E., Sakiyama-Elbert S.E. Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater. 2009, 5:959-968.
64. Wood M.D., MacEwan M.R., French A.R., Moore A.M., Hunter D.A., Mackinnon S.E., Moran D.W., Borschel G.H., Sakiyama-Elbert S.E. Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration. Biotechnol. Bioeng. 2010, 106:970-979.
65. Yang R.K., Lowe J.B., Sobol J.B., Sen S.K., Hunter D.A., Mackinnon S.E. Dose-dependent effects of FK506 on neuroregeneration in a rat model. Plast. Reconstr. Surg. 2003, 112:1832-1840.
66. Yeh C., Bowers D., Hadlock T.A. Effect of FK506 on functional recovery after facial nerve injury in the rat. Arch. Facial Plast. Surg. 2007, 9:333-339.
67. Zhao Z., Alam S., Oppenheim R.W., Prevette D.M., Evenson A., Parsadanian A. Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy. Exp. Neurol. 2004, 190:356-372.